PNOC019: Neoadjuvant Checkpoint Inhibition in Recurrent or Progressive HGG - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults, Children
Study Details
Full Title
A Randomized, Double-Blinded, Pilot Trial of Neoadjuvant Checkpoint Inhibition followed by Combination Adjuvant Checkpoint Inhibition in Children and Young Adults with Recurrent or Progressive High Grade Glioma (HGG)
Principal Investigator
Neuro-oncologist
Protocol Number
IRB:
PRO00109073
NCT:
NCT04323046
Phase
Phase
Pilot
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Call 919-684-5301